Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""7512719"" wg kryterium: JN


Tytuł :
Re: Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction.
Autorzy :
Goldman HB; Glickman Urologic and Kidney Institute, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec 01. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Trial.
Autorzy :
Wu Z; Department of Urology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China.
Wang L; Department of Urology, Shanghai Changhai Hospital, Naval Medical University, Shanghai, China.
Pandolfo SD; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
Autorino R; Department of Urology, Rush University Medical Center, Chicago, IL, USA. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec 01. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Re: Spatially Resolved Clonal Copy Number Alterations in Benign and Malignant Tissue.
Autorzy :
Axcrona K; Department of Urology, Akershus University Hospital, Lørenskog, Norway; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway. Electronic address: .
Aas K; Department of Urology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Axcrona U; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway; Department of Pathology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Skotheim RI; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway; Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec 01. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Can We Measure the Academic Impact of Social Media?
Autorzy :
Rivas JG; Department of Urology. Hospital Clinico San Carlos, Madrid, Spain; Young Academic Urologists, European Association of Urology, Arnhem, The Netherlands. Electronic address: .
Teoh JY; Young Academic Urologists, European Association of Urology, Arnhem, The Netherlands; Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Cacciamani G; Young Academic Urologists, European Association of Urology, Arnhem, The Netherlands; Keck School of Medicine, Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 637-638. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Social Media*
Education*
Humans
Opinia redakcyjna
Tytuł :
Genitourinary Lesions Due to Monkeypox.
Autorzy :
Gomez-Garberi M; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Sarrio-Sanz P; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain. Electronic address: .
Martinez-Cayuelas L; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Delgado-Sanchez E; Internal Medicine Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Bernabeu-Cabezas S; Centre d'Informació i Prevenció del Sida, Alicante, Spain.
Peris-Garcia J; Internal Medicine Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Sanchez-Caballero L; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Nakdali-Kassab B; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Egea-Sancho C; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Olarte-Barragan EH; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Ortiz-Gorraiz MA; Urology Service, University Hospital of San Juan de Alicante, San Juan de Alicante, Spain.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 625-630. Date of Electronic Publication: 2022 Sep 09.
Typ publikacji :
Observational Study; Journal Article
MeSH Terms :
Monkeypox*/diagnosis
Monkeypox*/pathology
Humans ; Male ; Adult ; Prospective Studies
Czasopismo naukowe
Tytuł :
Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series.
Autorzy :
Marra G; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy; Department of Urology, Institut Mutualiste Montsouris and Université Paris Descartes, Paris, France; Department of Urology, Hôpital Tenon, Paris, France. Electronic address: .
Agnello M; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Giordano A; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Soria F; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Oderda M; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Dariane C; Department of Urology, Hôpital Européen Georges Pompidou and Necker Hospital, Paris, France.
Timsit MO; Department of Urology, Hôpital Européen Georges Pompidou and Necker Hospital, Paris, France.
Branchereau J; Institut de Transplantation Urologie Néphrologie, CHU Nantes, Nantes, France.
Hedli O; Institut de Transplantation Urologie Néphrologie, CHU Nantes, Nantes, France.
Mesnard B; Institut de Transplantation Urologie Néphrologie, CHU Nantes, Nantes, France.
Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey.
Olsburgh J; Department of Urology, Guy's Hospital, London, UK.
Kulkarni M; Department of Urology, Guy's Hospital, London, UK.
Kasivisvanathan V; Department of Urology, Guy's Hospital, London, UK; Division of Surgery, University College London, London, UK.
Breda A; Department of Urology, Fundacio Puigvert, Barcelona, Spain.
Biancone L; Department of Nephrology, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Gontero P; Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
Pokaż więcej
Corporate Authors :
collaborators
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 639-645. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji :
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Robotic Surgical Procedures*/adverse effects
Robotic Surgical Procedures*/methods
Robotics*
Kidney Transplantation*/adverse effects
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Humans ; Male ; Prostate/pathology ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Kidney/physiology ; Kidney/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441.
Autorzy :
Zapatero A; Department of Radiation Oncology, Hospital Universitario de La Princesa, Health Research Institute, Madrid, Spain. Electronic address: .
Calvo FA; Radiation Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Radiation Oncology Department, Clínical Universitaria de Navarra, Madrid, Spain.
Gonzalez San-Segundo C; Radiation Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Alvarez A; Radiation Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. e177-e178. Date of Electronic Publication: 2022 Sep 15.
Typ publikacji :
Randomized Controlled Trial; Clinical Trial, Phase III; Letter; Comment
MeSH Terms :
Androgen Antagonists*/therapeutic use
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/drug therapy
Humans ; Male ; Androgens/therapeutic use
Raport
Tytuł :
Re: A Randomized, Single-blind Clinical Trial Comparing Robotic-assisted Fluoroscopic-guided with Ultrasound-guided Renal Access for Percutaneous Nephrolithotomy.
Autorzy :
Ventimiglia E; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: .
Corsini C; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Montorsi F; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Salonia A; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Goumas IK; Department of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 660-661. Date of Electronic Publication: 2022 Sep 23.
Typ publikacji :
Randomized Controlled Trial; Journal Article
MeSH Terms :
Nephrolithotomy, Percutaneous*
Robotic Surgical Procedures*
Kidney Calculi*/diagnostic imaging
Kidney Calculi*/surgery
Nephrostomy, Percutaneous*
Humans ; Single-Blind Method ; Fluoroscopy ; Ultrasonography, Interventional ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Re: Sequential Intravesical Gemcitabine and Docetaxel for Bacillus Calmette-Guérin-naïve High-risk Nonmuscle-invasive Bladder Cancer.
Autorzy :
Kavoussi M; Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA.
Nasrallah AA; Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA.
Williams SB; Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 659. Date of Electronic Publication: 2022 Sep 08.
Typ publikacji :
Journal Article
MeSH Terms :
Urinary Bladder Neoplasms*/drug therapy
Bacillus*
Humans ; Docetaxel/therapeutic use ; BCG Vaccine/therapeutic use ; Administration, Intravesical ; Neoplasm Invasiveness ; Adjuvants, Immunologic/therapeutic use ; Neoplasm Recurrence, Local/drug therapy
Czasopismo naukowe
Tytuł :
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Autorzy :
Schilham MGM; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Rijpkema M; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Scheenen T; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Hermsen R; Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Barentsz JO; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Michiel Sedelaar JP; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Kusters-Vandevelde H; Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Kerkmeijer LGW; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Somford DM; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Gotthardt M; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 578-580. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji :
Editorial
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/therapy
Humans ; Male ; Prostate/pathology ; Patient Selection ; Neoplasm Staging
Opinia redakcyjna
Tytuł :
Methods Modernizing Statistical Reporting in Medical Journals: Challenges and Future Directions.
Autorzy :
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: .
Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 575-577. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji :
Editorial; Research Support, N.I.H., Extramural
MeSH Terms :
Periodicals as Topic*
Biomedical Research*
Humans ; Research Design
Raport
Tytuł :
Re: Kara N. Maxwell, Heather H. Cheng, Jacquelyn Powers, et al. Inherited TP53 Variants and Risk of Prostate Cancer. Eur Urol 2022;81:243-50: Off-core Li-Fraumeni Syndrome Spectrum Cancers: Increasing Interest for Prostate Cancer?
Autorzy :
Sassi H; Tumor Genetic Section, Medical Biology and Pathology Department, Insitut Gustave Roussy, Villejuif, France. Electronic address: .
Caron O; Oncogenetic Department, Insitut Gustave Roussy, Villejuif, France.
Rouleau E; Tumor Genetic Section, Medical Biology and Pathology Department, Insitut Gustave Roussy, Villejuif, France; AMMICa UAR3655/US23, Insitut Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. e172-e173. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji :
Letter; Comment
MeSH Terms :
Li-Fraumeni Syndrome*/genetics
Prostatic Neoplasms*/genetics
Humans ; Male ; Germ-Line Mutation ; Tumor Suppressor Protein p53/genetics ; Genetic Predisposition to Disease
Opinia redakcyjna
Tytuł :
Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. JAMA 2022;327:2092-103: Lacking the Evidence for Neobladder Use After Radical Cystectomy.
Autorzy :
Catto JWF; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Division of Surgery & Interventional Science, University College London, London, UK. Electronic address: .
Khetrapal P; Division of Surgery & Interventional Science, University College London, London, UK.
Ambler G; Department of Statistical Science, University College London, London, UK.
Williams NR; Surgical & Interventional Trials Unit, Division of Surgery & Interventional Science, University College London, London, UK.
Brew-Graves C; National Cancer Imaging Translational Accelerator, Division of Medicine, University College London, London, UK.
Kelly JD; Division of Surgery & Interventional Science, University College London, London, UK.
Pokaż więcej
Corporate Authors :
iROC Study Team
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. e167-e168. Date of Electronic Publication: 2022 Sep 14.
Typ publikacji :
Randomized Controlled Trial; Letter
MeSH Terms :
Urinary Bladder Neoplasms*/surgery
Robotics*
Urinary Diversion*
Humans ; Cystectomy ; Morbidity
Raport
Tytuł :
The Evolving Role of Locally Delivered Checkpoint Inhibitors in Non-muscle-invasive Bladder Cancer.
Autorzy :
Hayne D; Medical School, The University of Western Australia, Perth, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia; Department of Urology, Fiona Stanley Hospital, Murdoch, Australia. Electronic address: .
Redfern A; Medical School, The University of Western Australia, Perth, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Murdoch, Australia.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 611-612. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Urinary Bladder Neoplasms*/drug therapy
Carcinoma, Transitional Cell*
Humans ; Immunotherapy
Opinia redakcyjna
Tytuł :
BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up.
Autorzy :
Suarez-Cabrera C; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain. Electronic address: .
Estudillo L; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain.
Ramón-Gil E; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain.
Martínez-Fernández M; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Peral J; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Rubio C; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Lodewijk I; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Martín de Bernardo Á; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
García-Escudero R; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Villacampa F; Uro-Oncology Unit, University Hospital 12 de Octubre, Madrid, Spain.
Duarte J; Uro-Oncology Unit, University Hospital 12 de Octubre, Madrid, Spain.
de la Rosa F; Uro-Oncology Unit, University Hospital 12 de Octubre, Madrid, Spain.
Castellano D; Uro-Oncology Unit, University Hospital 12 de Octubre, Madrid, Spain.
Guerrero-Ramos F; Uro-Oncology Unit, University Hospital 12 de Octubre, Madrid, Spain.
Real FX; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre, Madrid, Spain; Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain.
Malats N; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain.
Paramio JM; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
Dueñas M; Biomedical Research Institute, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 663-667. Date of Electronic Publication: 2022 Sep 06.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
MicroRNAs*/genetics
Humans ; Follow-Up Studies ; Urinary Bladder ; Biomarkers, Tumor/genetics
Raport
Tytuł :
Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology.
Autorzy :
Klaassen Z; Section of Urology, Department of Surgery, Medical College of Georgia-Augusta University, Augusta, GA, USA; Georgia Cancer Center, Augusta, GA, USA. Electronic address: .
Vertosick E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Assel MJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Novara G; Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua, Padua, Italy.
Pierce C; European Association of Urology, Arnhem, The Netherlands.
Wallis CJD; Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada; Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
Larcher A; Department of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cooperberg MR; Department of Urology, University of California-San Francisco Medical Center, San Francisco, CA, USA.
Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK.
Kutikov A; Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 633-636. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji :
Randomized Controlled Trial; Journal Article
MeSH Terms :
Social Media*
Urology*
Humans ; Male ; Prospective Studies
Czasopismo naukowe
Tytuł :
Re: Jens Bedke, Brian I. Rini, Elizabeth R. Plimack, et al. Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma. Eur Urol. 2022;82:427-39.
Autorzy :
Zhao B; Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. e174-e175. Date of Electronic Publication: 2022 Sep 26.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Humans ; Sunitinib/therapeutic use ; Axitinib ; Quality of Life ; Antineoplastic Combined Chemotherapy Protocols
Opinia redakcyjna
Tytuł :
Shaping the Undergraduate Curriculum in Europe: Consensus Statement from the European School of Urology.
Autorzy :
Gómez Rivas J; Department of Urology, Hospital Clínico San Carlos, Madrid, Spain. Electronic address: .
Somani B; University Hospital Southampton NHS Trust, Southampton, UK.
Rodriguez Socarrás M; Instituto de Cirugía Urológica Avanzada, Madrid, Spain.
Marra G; Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy.
Pearce I; Manchester University NHS Foundation Trust, Manchester, UK.
Henningsohn L; Department of Urology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Zondervan P; Amsterdam University Medical Centers, Department of Urology, Amsterdam, The Netherlands.
Van Poppel H; Department of Urology, Katholieke Universiteit, Leuven, Belgium.
N'Dow J; Academic Urology Unit, University of Aberdeen, Aberdeen, UK.
Liatsikos E; Department of Urology, University Hospital of Patras, Patras, Greece.
Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 581-583. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji :
Editorial
MeSH Terms :
Urology*/education
Education, Medical, Undergraduate*
Humans ; Curriculum ; Europe ; Consensus
Opinia redakcyjna
Tytuł :
Monkeypox and the Urologist: Playing an Important Role in This Emerging Global Outbreak.
Autorzy :
Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 631-632. Date of Electronic Publication: 2022 Sep 24.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Monkeypox*/epidemiology
Humans ; Urologists ; Disease Outbreaks
Opinia redakcyjna
Tytuł :
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.
Autorzy :
Strandgaard T; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lindskrog SV; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Nordentoft I; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Christensen E; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Birkenkamp-Demtröder K; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Andreasen TG; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lamy P; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Kjær A; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Ranti D; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Wang YA; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Bieber C; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Prip F; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Rasmussen J; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Steiniche T; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Birkbak N; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Sfakianos J; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Horowitz A; Department of Oncological Sciences, Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2022 Dec; Vol. 82 (6), pp. 646-656. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
BCG Vaccine*/adverse effects
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/drug therapy
Humans ; Adjuvants, Immunologic/therapeutic use ; Administration, Intravesical ; DNA, Neoplasm ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Retrospective Studies ; T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies